US 11053261
Solid state forms of ixazomib citrate
granted A61KA61K31/69A61P
Quick answer
US patent 11053261 (Solid state forms of ixazomib citrate) held by TEVA PHARMACEUTICALS INTERNATIONAL GMBH expires Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICALS INTERNATIONAL GMBH
- Grant date
- Tue Jul 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/69, A61P, A61P35/00